Audit: unverified claims

Collected from all *(unverified)* tags in wiki/ (21 tags across 13 notes). “Not in raw/” means the round-14 fact-check found no saved source text supporting the claim (FACTCHECK_SPEC step 2).

  • Aciclovir — “IV aciclovir can crystallise in the kidneys; prevented by hydration” — only a Medscape 2002 search result; page not saved
  • Aciclovir — “Recurrent eczema herpeticum may be offered antiviral prophylaxis” — only a Medscape 2002 search result; page not saved
  • Crisaborole — “PDE4 blockade reduces IL-4 and IL-5 release (EMA Staquis overview)” — EMA overview wording not found in raw/
  • Crisaborole — “Pfizer dropped remaining EU paediatric investigation plan studies for business reasons” — EMA variation report not saved
  • Crisaborole — “KOLs see PDE4 class as having ‘limited class efficacy’ (GlobalData 2022)” — search snippet only, not fetched; industry-analyst source
  • Crisaborole — “EU product information: 90 mg propylene glycol per gram” — EU SmPC excipient line not in raw/
  • Essential Oils — “Tea tree oil has caused more published allergic reactions than any other essential oil” — not in raw/; no primary review supporting the ranking saved
  • Fusidic Acid — “Recent topical use the only independent risk factor for resistant staph (adjusted OR 7.5)” — earlier audits cited from search results; abstracts not saved
  • Fusidic Acid — “Restricting topical fusidic acid in one unit lowered resistance” — cited in search results; abstracts not saved
  • Olive Oil — “Verallo-Rowell 2008: objective SCORAD fell on olive oil (36.6 → 26.7)” — figures not confirmed against saved trial text
  • Olive Oil — “Adult said an olive oil and sugar scrub was ‘fine’ for her skin” — single forum anecdote; thread not found in raw/
  • Phototherapy — “Broadband UVB, UVA1, PUVA now rarely used; AAD advises against PUVA” — AAD PUVA recommendation not found in raw/ (2026 guideline tables paywalled)
  • Shea Butter — “FDA removed shea from the tree-nut list in 2025” — Allergic Living page returned 403; no FDA primary source saved
  • Sunflower Seed Oil — “An earlier Egyptian preterm trial reported similar results” — secondary mention only; trial text not saved
  • Sunflower Seed Oil — “Later Nepal cluster trial and meta-analyses gave mixed results” — not in raw/
  • Sunflower Seed Oil — “84% of peanut-allergic children exposed to peanut-oil creams vs 53% of controls” — ALSPAC press release not saved; figures not found in raw/
  • Systemic Immunosuppressants — “NIHR economic evaluation: methotrexate effective, low-cost first-line systemic” — PubMed 41337631 search snippet only
  • Tapinarof Cream — “AhR activation dampens cytokines and supports the skin barrier” — mechanism not in saved sources; FDA label says mechanism “unknown”
  • Weekend Therapy — “Hywel Williams editorial: ~2 treated with fluticasone vs 4 with tacrolimus to prevent one flare” — editorial not saved in raw/
  • Written Eczema Action Plan — “Shi 2013: EAP group better flare recognition/management and more comfort with self-management” — raw/ (guidance-registries/source-3) only says “significant improvement”; specific outcomes unconfirmed
  • Written Eczema Action Plan — “Eczema Care Online links an action plan to fill in with a clinician” — not found in saved Eczema Care Online pages